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Abstract: 
Alpha-synuclein oligomers can be toxic to cells and may be responsible for cell death 
in Parkinson’s disease. Their typically low abundance and highly heterogeneous nature, 
however, make such species challenging to study using traditional biochemical 
techniques. By combining fast-flow microfluidics with single-molecule fluorescence, we 
are able to rapidly follow the process by which oligomers of αS are formed, and to 
characterize the species themselves. We have used the technique to show that populations 
of oligomers with different FRET efficiencies have varying stabilities when diluted into 
low ionic strength solutions. Interestingly, we have found that oligomers formed early in 
the aggregation pathway have electrostatic repulsions that are shielded in the high ionic 
strength buffer, and therefore dissociate when diluted into lower ionic strength solutions. 
This property can be used to isolate different structural groups of αS oligomers and can 
help to rationalize some aspects of αS amyloid fibril formation. 
Introduction 
Parkinson’s disease (PD) is the second most common neurodegenerative disease after 
Alzheimer’s disease1, affecting more than 1% of the world’s population of those aged 
over 65 years2. Clinically, the disorder is characterized by a loss of control of movement, 
and the onset of resting tremors, muscle rigidity and bradykinesia. Additionally, there are 
non-motor characteristics, such as cognitive impairment, depression, olfactory deficits, 
psychosis, and sleep disturbance during the progression of the disease3. 
Neuropathologically, PD is characterized by the progressive loss of dopaminergic 
neurons within the substantia nigra pars compacta of the midbrain. One of the major 
pathological hallmarks of PD is the presence of intra-neuronal proteinaceous cytoplasmic 
inclusions, referred to as Lewy Bodies (LBs). The finding that amyloid fibrils of the 
protein alpha-synuclein (αS) are a major component of LBs suggests that it is involved in 
the etiology of the disease4. LBs are also found in other neurodegenerative disorders such 
as Dementia with LBs, the LB variant of AD5 and Down’s Syndrome6. Duplication7 and 
triplication8 of the chromosomal region surrounding the gene coding for αS, and a 
number of point mutations8–13 lead to dominantly inherited PD, providing further 
evidence for the link between the protein and the diseases.  
The finding that purified recombinant αS forms fibrils resembling those found in LBs14 
has led to speculation that aggregation plays a key role in the disease. When αS 
aggregates in vitro, small soluble oligomers, which have been shown to be cytotoxic, are 
generated15–17, and such species can, in some cases, progress directly into fibrillar 
structures. Despite the evidence of their importance to the disease, the usually low 
abundance and highly heterogeneous nature of the oligomeric species formed during the 
aggregation reaction make them difficult to study using traditional biochemical 
techniques. We have previously used single-molecule fluorescence techniques to 
characterize the aggregation and behavior of amyloid oligomers of the SH3 domain of 
PI3 kinase18, the amyloid-beta peptide19,20 and αS16. For the latter, we used single-
molecule Förster Resonance Energy Transfer (FRET) to show that αS initially forms 
amorphous oligomers having a low FRET efficiency, which consequently undergo a 
structural rearrangement to form proteinase-K resistant, cytotoxic oligomers, having a 
higher FRET efficiency16.  
The oligomers of αS generated during fibril formation typically only make up a small 
fraction of the total protein concentration, and so single-molecule techniques are needed 
to detect their presence and characterize their structures. The picomolar concentrations 
required for single-molecule detection, however, mean that a significant time is needed to 
collect enough data to make useful conclusions. Through incorporating fast-flow 
microfluidics (Figure 1) to rapidly pass the low concentration solutions through the 
confocal volume (at a velocity of 2 cm/s), we have now reduced the data acquisition time 
from 3 hours, to just over 5 minutes per time-point, thereby allowing us to increase 
drastically the time-resolution of our technique, and also to run several aggregations on 
one instrument simultaneously. In this paper, we illustrate the power of this technique by 
studying in more detail the aggregation of αS.  
The conformation of monomeric αS is affected by factors such as pH21 and ionic 
strength22, and we speculated that certain types of oligomers may be electrostatically 
destabilized due to inter monomer electrostatic repulsion because of the high net charge 
of the C-terminal region. To test this hypothesis, we used the increased data-acquisition 
rate of this technique to study the effect of diluting the time-points from the aggregation 
into high and low ionic strength buffers.  We found that the amorphous type oligomers, 
which are less cytotoxic, and more susceptible to proteinase-K digestion, dissociate at 
low ionic strengths, whereas the higher FRET species are stable to such a change in 
conditions. 
 
Figure 1. A. Instrumental setup. The microfluidic device is mounted onto a confocal 
microscope in which 488 nm radiation is focused down to a diffraction-limited spot 
within the 100 µm wide channel. Fluorescence from Alexa Fluor 488 (AF488) and Alexa 
Fluor 594 (AF594) (excited indirectly via FRET) can then be collected, and separated 
onto two separate Avalanche photodiode detectors (APDs). B. Example intensity traces. 
Bursts of intensity arise when fluorescently labeled αS transits the confocal volume. 
Oligomeric species have a burst in both the donor (blue trace) and acceptor (orange 
trace) channel, allowing them to be separated from the majority of monomeric protein 
(donor bursts only).  	  
RESULTS AND DISCUSSION 
Microfluidic device design 
In order to determine whether an increase in the data acquisition rate for αS aggregation 
samples could be achieved using fast-flow, a simple microfluidic device was designed 
and made from PDMS. The device consists of a single channel, 100 µm in width, 25 µm 
in height and 1 cm in length. The width and height were selected to prevent larger fibrils 
blocking the device, and this is demonstrated by the constant monomer and oligomer 
detection rate over the duration of the measurement, even at later time-points when fibrils 
are present (Figure 2B and C.). The aggregation samples were diluted before being 
loaded into a low-binding gel-loading tip, which was inserted into the entry port of the 
device (Figure 2A.). Tubing connected to a syringe within a syringe pump was attached 
to the exit port, allowing for accurate control of the flow-velocity by application of a 
negative pressure. By withdrawing sample in this way, rather than infusing sample 
directly from a syringe, the dead volume was minimal, and the exposure of the samples to 
hydrophobic surfaces, such as the inside of plastic tubing, was minimized.  
 
	  
Figure 2. A. Device design. The microfluidic chip consists of a single-channel, 100 μm 
in width, and 25 μm in height, red scale bar is 500 µm in length. A gel-loading tip 
containing the analyst is added to the sample inlet, and the outlet is attached to a syringe 
within a syringe pump to pull sample through the device. Zoom: Brightfield image of the 
microfluidic device channel (scale bar is 100 µm in length). B. and C. Cumulative 
frequency histogram of monomeric and oligomeric events, respectively, over a 400s 
measurement of 280 pM aggregated αS. The histograms are fitted to a straight line 
yielding R2 = 0.999 and R2 = 0.998 for monomeric, and oligomeric events, respectively. 
This shows that the event detection rate remains constant over the measurement time. 
  
Increase in data acquisition rate with fast flow microfluidics 
Many steps in protein aggregation reactions are likely to take place on time-scales that 
are shorter than the 3 h time points used in our previous study on the oligomers formed 
during the aggregation of αS16. We sought to increase the time resolution by using fast 
flow microfluidics. It has previously been shown that it is possible to increase the rate of 
data acquisition in single-molecule confocal experiments by flowing the molecules 
through the probe volume at high speeds (see Figure 1)23. There is, however, an upper 
limit to the velocity at which molecules can flow through the confocal volume whilst still 
enabling the collection of meaningful data. At higher speeds, there is an increase in the 
rate at which fluorescent species transit the probe volume; in parallel, there is, however, a 
decrease in the number of excitation-emission cycles of the fluorophores, reducing event 
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brightness. Thus, there is an optimum velocity at which the event rate is high, but the 
brightness of the fluorescent bursts is not sufficiently low to make them undetectable. 
With two-color excitation, the rate at which it is possible to flow and still get meaningful 
data is higher than for the FRET experiments in which only one color is directly excited. 
For the work presented here, only the donor dyes are directly excited, and the presence of 
signal in the acceptor channel due to FRET is used to identify the oligomers in the 
presence of an excess of monomers. The oligomers, however, typically have more than 
one donor fluorophore present, and so it is possible to flow at higher velocities than those 
used for detecting species with only one directly excited donor dye.   
To determine the optimum flow velocity for our experiment, an aliquot of αS solution 
was removed after incubation under aggregation conditions for 24 hours and diluted to 
300 pM, before being flowed through a simple one-channel device mounted on the 
single-molecule confocal instrument at a range of velocities. With increasing flow 
velocity, it was necessary to increase the laser intensity, as under these conditions, the 
molecules spend less time in the confocal volume. The optimum intensities were 
determined previously23 by selecting those laser powers that gave the highest brightness 
at each velocity, up to the maximum power achievable on our instrumental set-up. The 
brightness of the bursts is also dependent on the flow velocity, and so it was necessary to 
vary the thresholds (see Supporting Information for details of thresholding and data 
analysis) in the donor and acceptor channels for each flow velocity. To achieve this in an 
unbiased way, we have previously23 shown that the thresholds at each flow velocity can 
be selected to give the maximum fraction of coincident fluorescent bursts in both 
channels using a dual labeled DNA duplex as an example24. The flow velocities, time 
bin-widths, and automatically selected thresholds are presented in SI Table 1. Figure 3 
shows the effect of varying flow speed on the measured monomer brightness (A), and the 
donor channel burst-rate (B). Even with the increase in laser power that can be used at 
higher flow velocities, the monomer brightness decreases due to the molecules spending 
less time in the probe volume, and therefore completing fewer excitation-emission cycles. 
However, with increasing flow velocity, the donor burst-rate initially increases, reaching 
a maximum of 530 ± 115 burst s-1 at a rate of 5 cm/s. At higher velocities, there is a 
decrease in the number of monomers detected, as the dye molecules are unable to emit 
enough photons to be detected above the applied thresholds.  
 
 
Figure 3. The effect of flow velocity on A. the measured mean monomer brightness, and 
B. the monomer burst rate (mean ± S.D., n = 3) when 280 pM of αS was passed through 
the microfluidic channel at varying flow velocities. With increasing flow velocity, the 
intensity of the bursts decreases due to fewer excitation-relaxation cycles in the shortened 
residence time in the probe volume. By contrast, the donor burst-rate initially increases, 
due to a faster encounter rate with the probe volume, but then decreases as a larger 
proportion of the molecules become insufficiently bright to detect. 	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As the oligomers are likely to contain more than one donor-labeled molecule, they are 
brighter than the monomer alone, and have a greater probability of emitting sufficient 
photons to be detected above the threshold level at higher flow velocities. Figure 4A 
shows the number of oligomers detected as a function of the mean flow velocity. As with 
the rate of monomer detection, there is an initial increase in the number of events 
detected as the flow velocity increases, before a slight decrease at higher velocities.  
The association quotient, Q (defined in the Supporting Information), indicates the 
fraction of molecules that simultaneously exhibit bursts of fluorescence above the applied 
thresholds in both detection channels. Figure 4B shows how Q varies as a function of 
flow velocity for the oligomeric sample solution. Increasing the mean flow velocity from 
0 to 0.5 cm s-1 leads to a slight increase in Q, as observed previously for dual-labeled 
DNA duplexes23. At higher velocities, there is a decrease in the Q value, due to the 
reduction in the brightness of the fluorophores, which are unable to complete sufficient 
excitation-emission cycles within the probe volume. In performing experiments under 
fast-flow, it is desirable that the flow velocity is high enough that many events are 
detected, but not so high that the number of photons detected limits the quality of the 
data. To take both of these factors into account in selecting the optimum flow velocity, 
the product of the event rate and Q against the varying flow speed was determined, and is 
plotted in Figure 4C. There is an increase in the product up to 2 cm/s, followed by a 
plateau at higher velocities indicating that a mean flow velocity of 2 cm/s is ideal for 
performing measurements of the oligomeric species under investigation here, since the 
event rate is increased (events are detected ~150 times more frequently than under static 
conditions), whilst the Q value is still reasonably high. 
  
 
Figure 4 A. The effect of increasing flow velocity on the oligomer event rate when a 
280pM sample of aggregated αS (starting monomer concentration) was passed through 
the microfluidic channel at varying flow velocities. With increasing flow rate, the event 
rate increases, making a plateau level after 2 cm/s, before decreasing slightly (mean ± 
S.D., n = 3). B. The association quotient as a function of flow velocity (mean ± S.D., n = 
3). There is a slight increase in the association quotient in changing the flow velocity 
from 0 to 0.5 cm/s; however, it decreases at higher velocities due to the fluorophores 
being less bright, and therefore less easily detectable. At higher velocities still (> 5 cm/s), 
the association constant slightly increases; however, this is due to the significant 
decrease in the monomer event rate (Figure 1B).  C. The product of the association 
quotient and event rate increases from 0 to 2 cm/s before plateauing (mean ± S.D., n = 
3).  
A further advantage of using microfluidic delivery to the confocal volume is that the 
flow velocity of the individual species is independent of their diffusivity/size, as the 
molecules are under laminar flow. In stationary measurements, relying on diffusion only, 
larger species are able to occupy the probe volume for a prolonged period of time, which 
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can lead to multiple counting of events.  In addition, the path taken through the confocal 
volume is more constant under flow (i.e. the molecules flow in one-dimension, rather 
than traveling through via Brownian motion), meaning that the transit time remains 
constant, and any intensity changes due to varying residence time are removed.  Also, 
since the flow is constant regardless of the species size, then species that are larger than 
the confocal volume diameter, such as fibrils, will occupy a greater number of time-bins 
than smaller species such as oligomers, as it takes a longer period of time for them to 
transit fully the confocal volume. This effect allows for fibrillar species to be separated 
from the smaller oligomeric events, which do not occupy multiple bins (see Supporting 
Information). 
 
Following the kinetics of an in vitro aggregation of αS 
 
 To determine the ability of the enhanced methodology to follow the in vitro formation 
of αS oligomers, solutions of αS were incubated under conditions favoring aggregation, 
and aliquots were taken and analysed at regular time intervals using single-molecule 
fluorescence. As monomers become incorporated into oligomers and fibrils, their 
numbers decrease, and this effect can be observed in Figure 4, which shows the number 
of donor fluorescent bursts detected above the applied threshold within the 400 s 
measurement time for the 50 hour time-course of the aggregation reaction.  
 
Figure 5. The change in the number of donor bursts measured over time during the 
aggregation of αS in 150 mM tris buffer with 100 mM NaCl (mean ± S.D., n = 3). The 
donor burst rate decreases as monomers are incorporated into oligomers and fibrils, 
because their concentration in solution is lower. 	  
For each event detected, the FRET efficiency and approximate size of the oligomer 
giving rise to it can be determined (see Supporting Information for details), and then 
binned into histograms (Figure 6A). As time progresses, the range of the sizes increases; 
after six hours of incubation, there are few events attributable to an oligomer containing 
more than 10 monomer units, whereas after 48 hours of incubation, a significant number 
of events have larger sizes of up to 50 monomer units. This is expected as the oligomers 
grow in size through monomer addition. It is also evident that there is a transition from 
species with a low FRET efficiency to those with a high FRET efficiency as the 
aggregation progresses. After six hours of incubation, 95.9% ±	  6.2% (mean	  ±	  S.D.,	  n	  =	  3)	  
of	   the	   3-­‐150mers	   are	   within	   the	   lower	   FRET	   efficiency	   population,	   whereas	   at	   48	  
hours,	   only	   37.8%	   ±	   4.2%	   (mean	   ±	   S.D.,	   n=3)	   of	   them	   are	   within	   the	   lower	   FRET	  
population.	   
By generating FRET efficiency histograms from events corresponding to dimers, and 
species greater in size than trimers, it is possible to observe a change in the FRET 
efficiency more easily (Figure 6B). For the smaller apparently dimeric oligomers, only 
one FRET population is observed, although this could be a mixture of the two 
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populations observed for larger species (it also has a FRET efficiency in between those of 
the two populations of larger species), but since the events must have a greater number of 
photons than the applied thresholds in both the donor and acceptor channel, events with 
either very high or low FRET efficiencies and few emitted photons may not be detected, 
and this may prevent the two peaks from being resolved for the smaller sized oligomers. 
For the larger oligomers, two peaks can be clearly resolved and fitted to Gaussian 
distributions. After integrating the fitted FRET histograms, the changes in the number of 
oligomers within each population can be plotted (Figure 6C). All three populations show 
an increase in the number of oligomers over time; for the low FRET form of the larger 
oligomers (corresponding to the “type A” oligomers identified previously16), the increase 
appears to occur rapidly after 2 hours of incubation, and continues at a high rate during 
the first 10 hours. For the higher FRET larger species (corresponding to the “type B” 
oligomers), the increase does not occur until after 8 hours of incubation, and then 
continues at a steady rate for the rest of the time-period. This delay in their presence can 
be attributed to the fact that they are formed from the conversion of type A oligomers. 
The apparent dimers show a gradual increase throughout the time-course, as this 
population is formed from a mixture of the low and high FRET species that cannot be 
separated due to low photon counts.  
In our previous study16, the single-molecule data were fit to a nucleation growth model 
with a conformational conversion step, and we have used the same kinetic analysis here 
to analyze the analogous data. The model assumes that primary nucleation results in the 
creation of oligomers of type A from monomeric protein molecules, and that type A 
oligomers can grow through monomer addition, or can convert into type B oligomers, 
resulting in several parallel pathways for the formation of type B oligomers of a given 
size (details of the early-time analytical and exact numerical solutions of the model are 
presented in the Supporting Information). Only the first six time-points here are fit with 
this model (Figure 6D.), since at later times, additional events, such as the formation of 
large fibrillar species, the contribution of the reverse processes involving conversion of 
type-B oligomers into type-A oligomers, and the dissociation of type-A oligomers, 
become significant and result in under-fitting of the data.  
This method of fitting generates two well-defined microscopic parameters; the primary 
nucleation rate constant for oligomers of type A was found to be 1.05 × 10−7 s−1, and the 
conversion rate constant from type A to type B oligomers as 2.02 × 10−5 s−1. These values 
are similar to those determined previously16, suggesting that the information obtained 
using single-molecule fluorescence and fast-flow microfluidics is fully consistent with 
the data taken without flow.  
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Figure 6.  A. 2D contour plots of size and FRET efficiency of various times from solutions 
of aggregating αS. The size and FRET efficiency both increase over time.  B. FRET 
efficiency histograms for various time-points taken during the aggregation of αS. The 
oligomers are separated into two different size groupings for which the populations were 
identified.  C. Kinetic traces for the three different populations of αS aggregates (mean	  ±	  
S.D.,	   n	   =	   3). There is an increase in the number of oligomers over time; however, the 
major increase for the type A oligomers occurs in the first 24 hours, whereas for the type 
B species, the increase is in the second 24 hours. D. Results of the global fitting of the 
kinetics of formation of the type A and type B oligomers (solid green and yellow lines, 
respectively). The fitting is performed on the first six data-points (up to 10 hours), before 
fibrils can be identified by the presence of a pellet after centrifugation at 15,000 r.p.m. 
for 15 minutes. 
 
Effect of varying ionic strength on the stability of oligomers: 
 
In order to probe the nature of the interactions within the oligomeric species, we 
studied the effect of ionic strength on their stability. We examined two different samples, 
one formed after 14 hours of incubation in which there are mainly type A oligomers and 
the other after 38 hours in which there are mainly the type B oligomers. These samples 
were diluted into a solution of 5 mM tris buffer at pH 7.4 containing varying 
concentrations of NaCl to change the ionic strength. The FRET efficiency histograms are 
shown in SI Fig. 3 and 4, and Figure 7 shows the number of oligomers detected from 
integrating the fitted FRET efficiency peaks. For the sample collected after 14 hours of 
aggregation, there is a noticeable increase in the number of detected events as the ionic 
strength of the dilution buffer is increased, suggesting that there are destabilizing charge 
repulsions in the earlier formed oligomers. Moreover, the destabilization (likely involving 
disaggregation) of the type A oligomers upon dilution into low ionic strength buffer 
conditions is rapid and occurs during the time it takes for the sample to be added to the 
instrument, since the same number of oligomeric events and FRET histograms are found 
when the sample is analyzed at later times.   For the sample taken after 38 hours of 
aggregation, however, there is no significant effect of the ionic strength on the detected 
oligomers. The more compact, higher FRET efficiency oligomers are less susceptible to 
changes in ionic strength, than the earlier formed oligomers, which appear to be 
destabilized by charge repulsion. In addition to shielding the charge interactions, the 
higher ionic strength can also increase the stabilizing hydrophobic interactions, which 
could also account for the oligomers dissociating at lower salt concentrations. 
Lowering the pH of the solution21, increasing the salt concentration25, or removing the 
C-terminal region of the protein has been demonstrated to drastically increase the rate of 
αS aggregation. Hoyer et al.26, and Dedmon et al.27 have suggested that the C-terminus 
interacts with the N-terminus in the monomeric form of the protein, shielding the NAC 
region, and preventing its self-assembly. At high ionic strengths, this interaction will be 
diminished, leading to an increased association of the monomers. However, the findings 
here suggest that it is not only the monomer conformation that is affected by varying the 
ionic strength of the solution, but the stability of the early-formed oligomers is also 
affected. At low ionic strengths, fewer early oligomers will be formed and therefore a 
decrease in the aggregation rate of the protein is expected as a consequence of a 
significant destabilization of these oligomers under those conditions. 
  
 
Figure 7. The effect of ionic strength on the number of events detected for aggregating 
samples of αS after 14 hours (A.) and 38 hours (B.) of aggregation (mean ± S.D., n = 3). 
The aggregation was done in 150 mM tris buffer with 100 mM NaCl, before being diluted 
into varying concentrations of NaCl. After 14 hours, there is a significant increase in the 
number of events detected with increasing sodium chloride concentration. After 38 hours, 
the effect of the varying ionic strength on the number of oligomers detected is not 
pronounced. 
In a second series of experiments, αS was incubated in 25 mM Tris buffer with 100 
mM NaCl under conditions favoring protein aggregation, and regular time-points were 
diluted into either 25 mM Tris with 100 mM NaCl, or into distilled water (pH 7) before 
being analyzed. Figure 8A shows the resulting 2D contour plots of size and FRET 
efficiency, FRET efficiency histograms are presented in Figure 8B, and the numbers of 
oligomers for each time-point when diluted into either Tris buffer, or distilled water are 
shown in Figure 9. The lower FRET efficiency oligomers (type A) were found to almost 
entirely dissociate on dilution into distilled water, whereas the high FRET efficiency 
oligomers (type B) are stable to dilution into distilled water, and do not dissociate. 
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Figure 8. A. Representative 2D contour plots of size and FRET efficiency showing the 
effect of diluting the samples from an aggregating sample of αS into either 25 mM tris 
buffer with 100 mM NaCl or into distilled water. B. Representative FRET efficiency 
histograms of dimers and larger oligomers generated when the samples were either 
diluted into either 25 mM tris buffer with 100 mM NaCl or distilled water.  	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Figure 9 Kinetic traces of the different types of oligomer diluted either into 25 mM Tris 
buffer with 100 mM NaCl, or into distilled water (mean ± S.D., n = 3).  The low FRET 
efficiency oligomers can be seen to be highly destabilized in low ionic strength solutions. 
By diluting the samples into distilled water, it is therefore possible to separate the high 
FRET efficiency oligomers from the lower FRET efficiency ones. These are the 
oligomers that were previously identified as being the cytotoxic species16, and this 
method highlights their greater stability, and allows them to be distinguished from the 
second population not only from their FRET efficiency, but also from their sensitivity to 
ionic strength.  
 
 
SUMMARY 
 
Through the use of a microfluidic device and fast-flow, it is possible to collect single-
molecule data 150 times faster than using stationary measurements. At the shorter time 
accessible by this approach, two different populations of oligomers are observed during 
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the aggregation, one exhibiting a lower FRET efficiency, and one resulting from the 
conversion of these into more compact oligomers having a higher FRET efficiency. The 
data generated using this method has been further analyzed by fitting it to a simple 
kinetic model in which type A oligomers are first formed before being converted to type 
B oligomers, both of which can grow in size via monomer addition. The kinetic 
parameters determined from this fitting are analogous to those previously determined. 
Overall, the developments have reduced the time required to analyze a dataset from three 
hours to just over five minutes, allowing for greater time resolution, and also several 
experiments to be run simultaneously on one instrument, since numerous samples can be 
measured back-to-back within a short period of time. 
The reduced time allows for further biophysical measurements to be made, and we 
have shown that by diluting the oligomeric samples into distilled water, the earlier 
formed lower FRET efficiency oligomers dissociate, possibly because of charge 
repulsions destabilizing the oligomers being less shielded. This finding allows for the 
isolation of the higher FRET efficiency, cytotoxic oligomeric species from a solution of 
oligomers, simply by changing the ionic strength of the buffer. Our findings substantiate 
the finding that there are two forms of oligomeric species generated when αS aggregates; 
not only do they differ in FRET efficiency and susceptibility to proteinase-K digestion, 
but they also behave differently when diluted into low ionic strength buffers.  
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 MATERIALS AND METHODS 
 
Protein expression and purification. BL21(DE3) Gold cells (Stratagene) were 
transformed with the Cys mutant A90C. Starters were diluted into Overnight Express™ 
Instant TB Medium (Novagen) supplemented with 1% glycerol and left to grow for 16-18 
h at 30°C. Following this, cells were harvested and the protein purified as previously 
published16.  
Device fabrication. Microfluidic channels were fabricated using standard soft-
lithography techniques into polydimethylsiloxane (PDMS; Dow Corning) with SU-8 
photoresist on silicon masters, as described previously23. The channels were plasma-
bonded to glass coverslides (V.W.R., thickness = 1) to create sealed devices. The channel 
height was 25 µm. Each device was inspected on a white-light microscope (Nikon Ti-U), 
and only those without dust or aberrations were used. 
Protein labeling. The Cys variant of wild-type αS was labeled as reported previously16. 
Life Technologies Alexa Fluor 488 C5 maleimide (AF488) and Alexa Fluor 594 C5 
maleimide (AF594) were used in these reactions. Labeled protein was isolated from 
unreacted dye using the method reported in Cremades et al., 201216. The reaction yield 
was checked by mass spectrometry for all reactions, and all labeling reactions with a 
yield lower than 90% were discarded.  
Single-molecule fluorescence measurements of aggregating αS. A 70 µM solution 
made up of equimolar concentrations of AF488 and AF594 labeled αS was prepared in 
25 mM Tris-HCl, pH 7.4, 100 mM NaCl. The buffer was freshly prepared before each 
experiment, and passed through a 0.02 µm syringe filter (Anotop, Whatman) to remove 
insoluble contaminants. The aggregation mixture was supplemented with 0.01% NaN3 to 
prevent bacterial growth, and was then incubated at 37oC with orbital shaking at 200 
r.p.m. (25 mm orbital diameter). Regular time-points were taken throughout the course of 
the aggregation and were immediately diluted by a factor of 1:250,000 (in two stages) 
before being loaded into a 200 µL gel-loading tip (Life technologies, Carlsbad, CA, 
USA) attached to the inlet port of a microfluidic channel (25 µm in height, 100 µm in 
width, 1 cm in length) mounted onto the single-molecule confocal microscope. The 
confocal volume was focused 10 µm into the center of the channel, and the solution was 
passed through the channel at an average velocity of 2 cm/s by applying a negative 
pressure, which was generated using a syringe pump (Harvard apparatus, Holliston, MA, 
USA) attached to the outlet port via Fine Bore Polyethylene Tubing (0.38 mm inner-
diameter, 1.09 mm outer-diameter; Smiths Medical International, Hythe, Kent, UK). 
Before adding the gel-loading tip, and withdrawing the sample, the syringe, tubing and 
microfluidic channel were first filled with buffer and any air-bubbles were purged from 
the system. After the appearance of single-molecule bursts corresponding to labeled αs 
passing through the confocal volume, the sample was measured for 400 s. There was no 
noticeable decrease in the event-rate over the duration of the measurement, suggesting 
that any surface absorbance does not affect the measurement.  
Single-molecule instrumentation. A Gaussian laser beam at a wavelength of 488 nm 
was first attenuated using neutral density filters, and passed through a spatial filter to 
before being directed through the back-port of an inverted microscope (Nikon Ti-U). A 
dichroic mirror (Di01-R405/488/594 Semrock) reflected the laser light through an oil-
immersion objective (Nikon CFI Plan Apochromat VC 60X Oil N2 NA 1.4, W.D 0.13 
mm), which focuses it to a diffraction-limited confocal spot within the sample being 
studied. The emitted fluorescence was collected by the same objective and passed 
through the dichroic, before being focused by a tube lens within the microscope body 
through a 50 µm pinhole (Thorlabs). A second dichroic (585DRLP Horiba) then separates 
the fluorescence from the two different fluorophores; the longer wavelength passes 
through the dichroic and was focused by a lens (Plano apo convex, focal length = 50 mm, 
Thorlabs) through a band pass filter (FF01-629/53) onto the Avalanche Photodiode 
(APD) detector. The shorter wavelength was reflected by the dichroic and is focused 
through a second set of filters (535AF55 Horiba, 540LP Omega) onto the second APD. 
Outputs from the two APDs are connected to a custom-programmed field-programmable 
gate array, FPGA (Colexica), which counts the signals and combines them into time-bins, 
which are selected according to the expected residence time of molecules traveling 
through the confocal volume.  
Stability in different ionic strength solutions. To determine the stability of different 
samples of αS oligomers with respect to varying ionic strength, the solution of αS  was 
diluted by a factor of 1:250,000 into a 5 mM tris buffer (pH 7.4) containing a range of 
NaCl concentrations (from 0 to 100 mM). The diluted sample was then immediately 
analyzed on the single-molecule confocal instrument. 
 
